Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193805-21-000433
Filing Date
2021-03-30
Accepted
2021-03-30 15:40:46
Documents
1
Group Members
DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT IV, L.P.DEERFIELD PRIVATE DESIGN FUND IV, L.P.

Document Format Files

Seq Description Document Type Size
1 e620432_sc13g-et.htm SC 13G 98123
  Complete submission text file 0001193805-21-000433.txt   99580
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G

Mailing Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE, 54TH FLR. NEW YORK NY 10022
Business Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE, 54TH FLR. NEW YORK NY 10022 212-739-6451
Edgewise Therapeutics, Inc. (Subject) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92424 | Film No.: 21786305
SIC: 2834 Pharmaceutical Preparations